Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Abstract Angiotensin‐converting enzyme inhibitors (ACEi) are part of the indicated treatment in hypertensive African Americans. ACEi have blood pressure‐independent effects that may make them preferred for certain patients. We aimed to evaluate the impact of ACEi on anti‐fibrotic biomarkers in Afric...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cesar A.Romero, Shobi Mathew, Benjamin Wasinski, Brian Reed, Aaron Brody, Rachelle Dawood, Michael J. Twiner, Candace D. McNaughton, Rafael Fridman, John M. Flack, Oscar A. Carretero, Phillip D. Levy
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2021-05-01
Col·lecció:	The Journal of Clinical Hypertension
Matèries:	ACE inhibitors Ac‐SDKP African American collagen left ventricular hypertrophy MMP‐1
Accés en línia:	https://doi.org/10.1111/jch.14206
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!